Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eiber

Showing results (321-330 of 377) with videos related to

Pageof 38
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2017
<sup>68</sup>Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2017
Most of the Intended Management Changes After <sup>68</sup>Ga-DOTATATE PET/CT Are ImplementedJeremie Calais, Johannes Czernin, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 15, 2026
Assessment of nephrotoxicity following lutetium-177 PSMA I&T radioligand therapy: a comparative study with docetaxel chemotherapyFlorian P Kirchhoff, Lisa Steinhelfer, Christian H Pfob, et al.
European Urology|March 19, 2023
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)Robert Seifert, Louise Emmett, Steven P Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2025
Multicentric Matched-Pair Analysis of Long-Term Hematotoxicity of Peptide Receptor Radionuclide Therapy in Patients PostsplenectomyLisa Steinhelfer, Friederike Jungmann, Lukas Endroes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2021
Head-to-head intra-individual comparison of biodistribution and tumor uptake of <sup>68</sup>Ga-FAPI and <sup>18</sup>F-FDG PET/CT in cancer patientsFrederik L Giesel, Clemens Kratochwil, Joel Schlittenhardt, et al.
European Urology|June 19, 2022
Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided SurgerySophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate CancerAndreea D Stuparu, Joseph R Capri, Catherine A L Meyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2020
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trialWolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2017
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesionsStefano Fanti, Silvia Minozzi, Joshua James Morigi, et al.
Pageof 38

Showing results (321-330 of 377) with videos related to

Sort By:
Pageof 38
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2017
<sup>68</sup>Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2017
Most of the Intended Management Changes After <sup>68</sup>Ga-DOTATATE PET/CT Are ImplementedJeremie Calais, Johannes Czernin, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 15, 2026
Assessment of nephrotoxicity following lutetium-177 PSMA I&T radioligand therapy: a comparative study with docetaxel chemotherapyFlorian P Kirchhoff, Lisa Steinhelfer, Christian H Pfob, et al.
European Urology|March 19, 2023
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)Robert Seifert, Louise Emmett, Steven P Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2025
Multicentric Matched-Pair Analysis of Long-Term Hematotoxicity of Peptide Receptor Radionuclide Therapy in Patients PostsplenectomyLisa Steinhelfer, Friederike Jungmann, Lukas Endroes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2021
Head-to-head intra-individual comparison of biodistribution and tumor uptake of <sup>68</sup>Ga-FAPI and <sup>18</sup>F-FDG PET/CT in cancer patientsFrederik L Giesel, Clemens Kratochwil, Joel Schlittenhardt, et al.
European Urology|June 19, 2022
Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided SurgerySophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate CancerAndreea D Stuparu, Joseph R Capri, Catherine A L Meyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2020
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trialWolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2017
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesionsStefano Fanti, Silvia Minozzi, Joshua James Morigi, et al.
Pageof 38